Treatment of Patient With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before Under and After Radiation and With Adding Cetuximab to K_RAS Wild-type Patients.
Phase 2
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Rectum Cancer
Both
Rectum Cancer
Trial Information
Treatment of Patient With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before Under and After Radiation and With Adding Cetuximab to K_RAS Wild-type Patients.
Dynamic MRI will be used to monitor the effect of the treatment and will be compared to
pathologic results.
Inclusion Criteria:
- advanced rectum cancer
Exclusion Criteria:
- prior radiation
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
response rate
Outcome Time Frame:
3 years
Safety Issue:
No
Authority:
Denmark: Danish Medicines Agency
Study ID:
GI0905
NCT ID:
NCT00964457
Start Date:
August 2009
Completion Date:
July 2017
Related Keywords:
- Rectum Cancer
- cetuximab
- rectum cancer
- radiation
- MRI
- Rectal Neoplasms
Name | Location |
|---|
